Orchid Pharma Board Meeting for Dhanuka Merger Share Allotment

Orchid Pharma Limited has issued a regulatory disclosure under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This communication serves as a prior intimation of a Board of Directors meeting scheduled for Saturday, August 01, 2026.

The primary agenda of the board meeting is the allotment of fully paid-up equity shares of ₹10 each to eligible shareholders of Dhanuka Laboratories Limited. The share allotment is being executed pursuant to the Scheme of Amalgamation of Dhanuka Laboratories Limited (the amalgamating company) with Orchid Pharma Limited (the amalgamated company).

The record date for determining eligible shareholders of Dhanuka Laboratories Limited has been fixed as July 23, 2026. Only shareholders recorded in Dhanuka Laboratories' records on this date will be eligible to receive equity shares of Orchid Pharma Limited.

This intimation is a continuation of an earlier communication dated July 10, 2026, and is formally addressed to both National Stock Exchange of India Limited and BSE Limited.